These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4147967)

  • 1. Further evidence for the heterogeneous storage of noradrenaline in central noradrenergic terminals.
    Thierry AM; Blanc G; Glowinski J
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 279(3):255-66. PubMed ID: 4147967
    [No Abstract]   [Full Text] [Related]  

  • 2. Release of ( 3 H)noradrenaline and ( 3 H)dopamine from field stimulated cerebral cortex slices. Effect of tyrosine hydroxylase and dopamine- -hydroxylase inhibition.
    Farnebo LO; Hamberger B; Jonsson G
    J Neurochem; 1971 Dec; 18(12):2491-500. PubMed ID: 4400156
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro inhibition of noradrenaline-3H uptake by reserpine and tetrabenazine in mouse cerebral cortex tissues.
    Ross SB; Renyi AL
    Acta Pharmacol Toxicol (Copenh); 1966; 24(1):73-88. PubMed ID: 4381156
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra.
    Nissbrandt H; Engberg G; Pileblad E
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):16-28. PubMed ID: 1663587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noradrenaline nerve terminals in the cerebral cortex: effects on noradrenaline uptake and storage following axonal lesion with 6-hydroxydopamine.
    Lidbrink P; Jonsson G
    J Neurochem; 1974 May; 22(5):617-26. PubMed ID: 4152079
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of desipramine on rat cortex slices incubated with 3H-dopamine.
    Gerlach J; Nielsen M; Randrup A
    Psychopharmacologia; 1974; 37(4):341-9. PubMed ID: 4851622
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of storage and catabolism in the accumulation of [3H]norepinephrine after short and long incubation times.
    Azzaro AJ; Smith DJ
    J Neurochem; 1975 Apr; 24(4):811-3. PubMed ID: 1123638
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of monoamine oxidase in determining the amount of monoamines released by drugs in the central nervous system.
    Rutledge CO; Azzaro AJ; Ziance RJ
    Adv Biochem Psychopharmacol; 1972; 5():379-92. PubMed ID: 5054209
    [No Abstract]   [Full Text] [Related]  

  • 9. The respective involvement of noradrenaline and its deaminated metabolites in waking and paradoxical sleep: a neuropharmacological model.
    Jones B
    Brain Res; 1972 Apr; 39(1):121-36. PubMed ID: 4402049
    [No Abstract]   [Full Text] [Related]  

  • 10. [Relationship between the antihypertensive activity of methyldopa and the appearance of its metabolites in the heart and brain of the hypertensive rat].
    Cohen Y; Wepierre J; Jacquot C; Rapin J
    Arch Int Pharmacodyn Ther; 1974 Feb; 207(2):348-60. PubMed ID: 4827419
    [No Abstract]   [Full Text] [Related]  

  • 11. The release of endogenous norepinephrine and dopamine from cerebral cortex by amphetamine.
    Arnold EB; Molinoff PB; Rutledge CO
    J Pharmacol Exp Ther; 1977 Sep; 202(3):544-57. PubMed ID: 894521
    [No Abstract]   [Full Text] [Related]  

  • 12. Presence of dopaminergic terminals and absence of dopaminergic cell bodies in the cerebral cortex of the cat.
    Thierry AM; Hirsch JC; Tassin JP; Blanc G; Glowinski J
    Brain Res; 1974 Oct; 79(1):77-88. PubMed ID: 4425954
    [No Abstract]   [Full Text] [Related]  

  • 13. Release of endogenous catecholamines from isolated rat brain tissue by fenfluramine and N-ethylamphetamine--effects of pargyline.
    Tessel RE; Burgess SK; Rutledge CO
    Biochem Pharmacol; 1978; 27(12):1631-6. PubMed ID: 697904
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of diphenylhydantoin on the uptake and catabolism of l-(3H)norepinephrine in vitro in rat cerebral cortex tissue.
    Azzaro AJ; Gutrecht JA; Smith DJ
    Biochem Pharmacol; 1973 Nov; 22(21):2719-29. PubMed ID: 4763605
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of noradrenaline pump blockers on its uptake by synaptosomes from several brain regions; additional evidence for dopamine terminals in the frontal cortex.
    Squires RF
    J Pharm Pharmacol; 1974 May; 26(5):364-7. PubMed ID: 4152863
    [No Abstract]   [Full Text] [Related]  

  • 16. Alpha 2-adrenoceptor-independent inhibition by imidazolines and guanidines of noradrenaline release from peripheral, but not central noradrenergic neurons.
    Göthert M; Molderings GJ; Fink K; Schlicker E
    Ann N Y Acad Sci; 1995 Jul; 763():405-19. PubMed ID: 7677354
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential effect of benserazide on catecholamine concentrations in the rat pineal, cerebral cortex and hypothalamus.
    Ho AK; Smith JA
    Biochem Pharmacol; 1983 Dec; 32(23):3605-9. PubMed ID: 6651878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between the action of monoamine oxidase inhibitors on the noradrenaline uptake system and their antidepressant efficacy.
    Hendley ED; Snyder SH
    Nature; 1968 Dec; 220(5174):1330-1. PubMed ID: 5701350
    [No Abstract]   [Full Text] [Related]  

  • 19. Rapid effects of monoamine oxidase inhibitors on synthesis and release of central monoamines.
    Glowinski J; Hamon M; Javoy F; Morot-Gaudry Y
    Adv Biochem Psychopharmacol; 1972; 5():423-39. PubMed ID: 4403372
    [No Abstract]   [Full Text] [Related]  

  • 20. Dopamine-norepinephrine: another regulatory step of norepinephrine synthesis in central noradrenergic neurons.
    Thierry AM; Blanc G; Glowinski J
    Eur J Pharmacol; 1971 May; 14(3):303-7. PubMed ID: 4405541
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.